Schrodinger, Inc. (SDGR) stock
SDGRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/3079% above fair value
$30.85−0.67 (-2.13%)
Close on Nov 12, 2026Market cap $2.31BP/E –Yield –
Schrodinger EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Schrodinger
Schrodinger has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?